Select Medical Holdings (NYSE: SEM) reported Q1 EPS of $0.21, $0.05 worse than the analyst estimate of $0.26. Revenue for the quarter came in at $1.09 billion versus the consensus estimate of $1.23 billion.

Business Outlook

Select Medical reaffirms its 2018 business outlook, provided in its January 8, 2018 press release, for net operating revenues and Adjusted EBITDA. Select Medical continues to expect consolidated net operating revenues for the full year 2018 to be in the range of $5.0 billion to $5.2 billion. Select Medical continues to expect Adjusted EBITDA for the full year 2018 to be in the range of $630.0 million to $660.0 million. Select Medical is adjusting its 2018 business outlook for fully diluted income per common share to include the first quarter 2018 loss on early retirement of debt and U.S. HealthWorks acquisition costs and their related tax effects. Select Medical now expects fully diluted income per common share for the full year 2018 to be in the range of $0.93 to $1.08. Select Medical expects adjusted income per common share to be in the range of $0.97 to $1.12. Adjusted income per common share excludes the loss on early retirement of debt and U.S. HealthWorks acquisition costs and their related tax effects.

GUIDANCE:

Select Medical Holdings sees FY2018 EPS of $0.93-$1.05, versus the consensus of $1.06. Select Medical Holdings sees FY2018 revenue of $5-5.2 billion, versus the consensus of $5.15 billion.

For earnings history and earnings-related data on Select Medical Holdings (SEM) click here.